What is the pathophysiology of seborrheic dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Seborrheic Dermatitis

Seborrheic dermatitis is a chronic inflammatory skin condition primarily caused by an abnormal inflammatory response to Malassezia yeasts, combined with skin barrier dysfunction, altered sebum composition, and host immune factors. 1

Core Pathophysiological Mechanisms

Malassezia Yeast Involvement

  • Malassezia species (lipophilic yeasts) are considered a primary trigger in seborrheic dermatitis 1, 2
  • These yeasts naturally colonize sebum-rich areas of the skin but can overgrow under certain conditions 3
  • The inflammatory reaction against Malassezia is fundamental to seborrheic dermatitis development 3
  • Malassezia can trigger both non-immune and immune-mediated inflammatory responses 3

Skin Barrier Dysfunction

  • Recent evidence shows significant skin barrier impairment in lesional skin of seborrheic dermatitis 4
  • Characterized by:
    • Altered ceramide subclass composition
    • Impaired chain elongation
    • Increased chain unsaturation
    • These changes correlate directly with barrier function impairment 4

Sebaceous Gland Activity

  • Occurs predominantly in sebum-rich areas (scalp, face, ears, chest, upper back) 1
  • Abnormal sebum production or composition creates favorable conditions for Malassezia overgrowth 5
  • Changes in sebaceous activity may precede Malassezia overgrowth rather than result from it 5

Immune System Dysregulation

  • Enhanced cell-mediated immunity to Malassezia has been detected in 40% of patients with chronic seborrheic dermatitis 6
  • Abnormal or inflammatory immune response to Malassezia contributes to disease manifestation 2
  • Genetic factors affecting host immunity may predispose to seborrheic dermatitis 5

Microbial Dysbiosis

  • Beyond Malassezia, broader skin microbiota changes are observed 4:
    • Increased Staphylococcus abundance
    • Decreased Cutibacterium abundance
  • These changes may contribute to inflammation and barrier dysfunction 4

Predisposing Factors

Medical Conditions

  • More pronounced in patients with:
    • HIV infection
    • Parkinson's disease
    • Down syndrome 1

Genetic Factors

  • Genetic studies have identified potential contributors:
    • ZNF750 mutation
    • Insights from Mpzl3 knockout mice with SD-like phenotypes 5

Environmental Factors

  • External factors can exacerbate the condition:
    • Climate changes
    • Stress
    • Irritants 1

Emerging Pathophysiological Model

Recent evidence suggests a shift from the traditional Malassezia-centric view to a more complex model where:

  1. Intrinsic host factors (altered sebum, defective epidermal barrier) create conditions favorable for Malassezia overgrowth 5
  2. Malassezia proliferation triggers inflammatory responses 3
  3. Skin barrier dysfunction perpetuates inflammation and symptoms 4
  4. Microbial dysbiosis further contributes to inflammation 4

This multifactorial pathophysiology explains why treatments targeting different aspects of the disease (antifungals, anti-inflammatories, barrier repair) can be effective in managing seborrheic dermatitis 7.

References

Guideline

Seborrheic Dermatitis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Role of antifungal agents in the treatment of seborrheic dermatitis.

American journal of clinical dermatology, 2004

Research

Seborrheic dermatitis-Looking beyond Malassezia.

Experimental dermatology, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.